Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: a prospective phase II study

DL Forrest, K Thompson, VG Dorcas… - Bone marrow …, 2003 - nature.com
We evaluated 40 patients undergoing high-dose chemo/radiotherapy (HDCT) and
hematopoietic stem cell transplantation (HSCT)(allogeneic (22), autologous (18)) to …

Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial [see …

M Attal, F Huguet, H Rubie, A Huynh, JP Charlet… - 1992 - ashpublications.org
Hepatic veno-occlusive disease (VOD) is a major regimen-related toxicity after bone marrow
transplantation (BMT). Endothelial injury, leading to deposition of coagulation factors within …

A randomized trial of heparin plus ursodiol vs heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation

SH Park, MH Lee, H Lee, HS Kim, K Kim… - Bone marrow …, 2002 - nature.com
Hepatic veno-occlusive disease (VOD) is a common and serious regimen-related toxicity
after hematopoietic stem cell transplantation (HSCT). There is no safe and proven therapy …

Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin

M Simon, T Hahn, LA Ford, B Anderson… - Bone Marrow …, 2001 - nature.com
This retrospective cohort study of 462 consecutive adult allogeneic and autologous blood or
marrow transplantation (BMT) patients compared the incidence of hepatic veno-occlusive …

Prophylactic heparin does not prevent liver veno‐occlusive disease following autologous bone marrow transplantation

L Marsa‐Vila, NC Gorin, JP Laporte… - European journal of …, 1991 - Wiley Online Library
Veno‐occlusive disease (VOD) is a major cause of toxic death after autologous bone
marrow transplantation (ABMT). We studied the potential role of continuous administration of …

LOW MOLECULAR WEIGHT HEPARIN FOR THE PREVENTION OF VENO-OCCLUSIVE DISEASE OF THE LIVER IN BONE MARROW TRANSPLANTATION …

R Or, A Nagler, O Shpilberg, S Elad, E Naparstek… - …, 1996 - journals.lww.com
Hepatic veno-occlusive disease (VOD), a common complication of bone marrow
transplantation (BMT), is a result of intensive conditioning by chemo-radiotherapy …

[HTML][HTML] Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: risk factors and stratification, prophylaxis, and treatment

JH Dalle, SA Giralt - Biology of Blood and Marrow Transplantation, 2016 - Elsevier
Hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome
(SOS), can develop in a subset of patients, primarily after myeloablative hematopoietic stem …

Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and …

E Carreras, H Bertz, W Arcese… - Blood, The Journal …, 1998 - ashpublications.org
To determine the incidence and outcome of hepatic veno-occlusive disease (VOD) after
blood or marrow transplantation (BMT), we prospectively evaluated all consecutive patients …

Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.

J Rosenthal, L Sender, R Secola, R Killen… - Bone marrow …, 1996 - europepmc.org
Veno-occlusive disease (VOD) of the liver is an early complication of bone marrow
transplantation (BMT). The initial event has been hypothesized to be an injury to the …

The incidence and risk factors of hepatic veno-occlusive disease after hematopoietic stem cell transplantation in Taiwan

CC Lee, HH Chang, MY Lu, YL Yang, SW Chou… - Annals of …, 2019 - Springer
Hepatic veno-occlusive disease (VOD) is a potentially fatal complication of hematopoietic
stem cell transplantation (HSCT). We conducted this study to investigate the incidence and …